Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Gastric Cancer

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 53 articles: HTML format

Single Articles

October 2025
1. YAZDI N, Pourjamal N, Katainen R, Vaananen J, et al
   Drug-tolerant persisting polyploid giant cancer cells mediate resistance to HER2-targeting antibody-drug conjugates.
   Cancer Lett. 2025;630:217900.
   PubMed     Abstract available
   
   
   August 2025
2. WU QN, Liao YF, Lu YX, Wang Y, et al
   Corrigendum to "Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance" [Cancer Lett. (2018) 412 243-255].
   Cancer Lett. 2025 Aug 19:217983. doi: 10.1016/j.canlet.2025.217983.
   PubMed    
   
   
   July 2025
3. LEE CK, Park S, Lee Y, Yun C, et al
   Efficacy of the first-line immune checkpoint inhibitor plus chemotherapy for gastroesophageal cancer: A meta-analysis of phase III trials including unreported PD-L1 subgroups.
   Cancer Lett. 2025;623:217718.
   PubMed     Abstract available
   
   
   
4. CHENG S, Luo Y, Dong X, Liu MY, et al
   Advanced Ensemble Staking Model Employing cfDNA Fragmentation for Early Detection of Esophageal and Gastric Cancer.
   Cancer Lett. 2025 Jul 23:217945. doi: 10.1016/j.canlet.2025.217945.
   PubMed     Abstract available
   
   
   
5. BU F, Ding G, Yang L, Wu Y, et al
   Lectin-affinity glycosylation pattern analysis of plasma extracellular vesicles: An all-in-one clinical assessment for gastric cancer diagnosis and treatment.
   Cancer Lett. 2025;631:217929.
   PubMed     Abstract available
   
   
   
6. HUANG W, Wang X, Zhong R, Li Z, et al
   Multimodal Radiopathomics Signature for Prediction of Response to Immunotherapy-based Combination Therapy in Gastric Cancer Using Interpretable Machine Learning.
   Cancer Lett. 2025 Jul 15:217930. doi: 10.1016/j.canlet.2025.217930.
   PubMed     Abstract available
   
   
   
7. SONG S, Fan Y, Zou G, Huo L, et al
   KAP1 promotes gastric adenocarcinoma progression by activating Hippo/YAP1 signaling via binding to HNRNPAB.
   Cancer Lett. 2025;621:217695.
   PubMed     Abstract available
   
   
   June 2025
8. GERAKOPOULOS V, Ramos C, Muller C, Walterskirchen N, et al
   Single-cell transcriptomic analysis identifies tissue-specific fibroblasts as the main modulators of myeloid cells in peritoneal metastasis of different origin.
   Cancer Lett. 2025;620:217678.
   PubMed     Abstract available
   
   
   
9. PENG J, Yin Y, Liu X, Deng C, et al
   CD51 promotes gastric cancer stemness via blocking Numb-mediated Notch1 degradation.
   Cancer Lett. 2025;629:217886.
   PubMed     Abstract available
   
   
   
10. YU S, Chen M, Jiang K, Chen C, et al
    CircSRPK1 mediated by the exon junction complex promotes gastric cancer progression by interacting with hnRNP A2B1 to regulate RON mRNA alternative splicing.
    Cancer Lett. 2025 Jun 16:217879. doi: 10.1016/j.canlet.2025.217879.
    PubMed     Abstract available
    
    
    
11. SHI Y, Zhao Z, Zhou S, Zhou Z, et al
    CHD4 drives gastric cancer metastasis via MYH9/GSK3beta/beta-catenin axis and WNT/EMT pathway activation.
    Cancer Lett. 2025;628:217813.
    PubMed     Abstract available
    
    
    May 2025
12. JIN Z, Zhang C, Shen L, Cao Y, et al
    Harnessing exosomes: From tumor immune escape to therapeutic innovation in gastric cancer immunotherapy.
    Cancer Lett. 2025;626:217792.
    PubMed     Abstract available
    
    
    April 2025
13. LI W, Wei H, Liu J, Zhao Z, et al
    Exosomal Biglycan Promotes Gastric Cancer Progression via M2 Polarization and CXCL10-Mediated JAK/STAT1 Activation.
    Cancer Lett. 2025 Apr 29:217758. doi: 10.1016/j.canlet.2025.217758.
    PubMed     Abstract available
    
    
    
14. LIU Q, Yu M, Lin Z, Wu L, et al
    COL1A1-positive endothelial cells promote gastric cancer progression via the ANGPTL4-SDC4 axis driven by endothelial-to-mesenchymal transition.
    Cancer Lett. 2025;623:217731.
    PubMed     Abstract available
    
    
    March 2025
15. LUO D, Wang H, Liu J, Chen X, et al
    Combined MDM2 and G2/M checkpoint inhibition induces synergistic antitumor response in gastric signet-ring cell carcinoma.
    Cancer Lett. 2025;613:217500.
    PubMed     Abstract available
    
    
    
16. YANG D, Zhang X, Hu Z, Sun Q, et al
    Organoid-based single cell sequencing revealed the lineage evolution during docetaxel treatment in gastric cancer.
    Cancer Lett. 2025 Mar 19:217617. doi: 10.1016/j.canlet.2025.217617.
    PubMed     Abstract available
    
    
    
17. WEI R, Song J, Liu C, Zhao Z, et al
    FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate T cells dysfunction and suppress anti-tumor immunity.
    Cancer Lett. 2025;612:217475.
    PubMed     Abstract available
    
    
    February 2025
18. LI N, Tong H, Hou W, Liu Q, et al
    Neural-cancer Crosstalk: Reciprocal Molecular Circuits Driving Gastric Tumorigenesis and Emerging Therapeutic Opportunities.
    Cancer Lett. 2025 Feb 25:217589. doi: 10.1016/j.canlet.2025.217589.
    PubMed     Abstract available
    
    
    
19. XU X, Huang Z, Han H, Yu Z, et al
    N(7)-methylguanosine tRNA modification promotes gastric cancer progression by activating SDHAF4-dependent mitochondrial oxidative phosphorylation.
    Cancer Lett. 2025;615:217566.
    PubMed     Abstract available
    
    
    
20. LI X, Lu J, Chen F, Yuan J, et al
    Comprehensive proteomic analysis and multidimensional model construction of peritoneal metastasis in gastric cancer.
    Cancer Lett. 2025 Feb 4:217509. doi: 10.1016/j.canlet.2025.217509.
    PubMed     Abstract available
    
    
    December 2024
21. MAK TK, Li K, Zhao Z, Wang K, et al
    m6A demethylation of NNMT in CAFs promotes gastric cancer progression by enhancing macrophage M2 polarization.
    Cancer Lett. 2024 Dec 24:217422. doi: 10.1016/j.canlet.2024.217422.
    PubMed     Abstract available
    
    
    
22. TSUTSUMI C, Ohuchida K, Tsutsumi H, Shimada Y, et al
    TIM3 on natural killer cells regulates antibody-dependent cellular cytotoxicity in HER2-positive gastric cancer.
    Cancer Lett. 2024 Dec 23:217412. doi: 10.1016/j.canlet.2024.217412.
    PubMed     Abstract available
    
    
    
23. YUAN J, Lu J, Zhu J, Chen F, et al
    LncRNA FIRRE drives gastric cancer progression via ZFP64-mediated TUBB3 promoter activation.
    Cancer Lett. 2024 Dec 18:217398. doi: 10.1016/j.canlet.2024.217398.
    PubMed     Abstract available
    
    
    November 2024
24. YOSHIMURA K, Zou G, Fan Y, Yamashita K, et al
    HSP90 Inhibitor AUY922 Suppresses Tumor Growth and Modulates Immune Response through YAP-TEAD Pathway Inhibition in Gastric Cancer.
    Cancer Lett. 2024 Nov 25:217354. doi: 10.1016/j.canlet.2024.217354.
    PubMed     Abstract available
    
    
    July 2024
25. YANG R, Kwan W, Du Y, Yan R, et al
    Corrigendum to "Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids" [Cancer Lett. 598 (2024) 217106].
    Cancer Lett. 2024 Jul 30:217127. doi: 10.1016/j.canlet.2024.217127.
    PubMed    
    
    
    
26. YANG R, Kwan W, Du Y, Yan R, et al
    Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids.
    Cancer Lett. 2024 Jul 9:217106. doi: 10.1016/j.canlet.2024.217106.
    PubMed     Abstract available
    
    
    
27. GOMAA A, Maacha S, Peng D, Soutto M, et al
    SOX9 is regulated by AURKA in response to Helicobacter pylori infection via EIF4E-mediated cap-dependent translation.
    Cancer Lett. 2024;593:216939.
    PubMed     Abstract available
    
    
    June 2024
28. LIM SH, Saluja A, Vickers S, Hong JY, et al
    The safety and efficacy outcomes of Minnelide given alone or in combination with paclitaxel in advanced gastric cancer: a Phase I trial.
    Cancer Lett. 2024 Jun 10:217041. doi: 10.1016/j.canlet.2024.217041.
    PubMed     Abstract available
    
    
    May 2024
29. LEI T, Lin Y, Lai X, Zhang Y, et al
    ITGB5 facilitates gastric cancer metastasis by promoting TGFBR2 endosomal recycling.
    Cancer Lett. 2024;592:216953.
    PubMed     Abstract available
    
    
    
30. XIA Y, Jiang T, Li Y, Gu C, et al
    circVAPA-rich small extracellular vesicles derived from gastric cancer promote neural invasion by inhibiting SLIT2 expression in neuronal cells.
    Cancer Lett. 2024 May 5:216926. doi: 10.1016/j.canlet.2024.216926.
    PubMed     Abstract available
    
    
    April 2024
31. ZHANG J, Fu L, Wang H, Yonemura A, et al
    RAC1-mediated Integrin alpha-6 expression in E-cadherin-deficient gastric cancer cells promotes interactions with the stroma and peritoneal dissemination.
    Cancer Lett. 2024 Apr 17:216901. doi: 10.1016/j.canlet.2024.216901.
    PubMed     Abstract available
    
    
    
32. CHEN J, Ji Y, Liu Y, Cen Z, et al
    Exhaled volatolomics profiling facilitates personalized screening for gastric cancer.
    Cancer Lett. 2024;590:216881.
    PubMed     Abstract available
    
    
    
33. WANG L, Mao X, Yu X, Su J, et al
    FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway.
    Cancer Lett. 2024 Apr 11:216841. doi: 10.1016/j.canlet.2024.216841.
    PubMed     Abstract available
    
    
    
34. ZHANG Y, Lin W, Yang Y, Zhu S, et al
    MEF2D facilitates liver metastasis of gastric cancer cells through directly inducing H1X under IL-13 stimulation.
    Cancer Lett. 2024 Apr 10:216878. doi: 10.1016/j.canlet.2024.216878.
    PubMed     Abstract available
    
    
    
35. WEN W, Ertas YN, Erdem A, Zhang Y, et al
    Dysregulation of autophagy in gastric carcinoma: Pathways to tumor progression and resistance to therapy.
    Cancer Lett. 2024 Apr 5:216857. doi: 10.1016/j.canlet.2024.216857.
    PubMed     Abstract available
    
    
    March 2024
36. RIEGEL G, Orvain C, Recberlik S, Spaety ME, et al
    The unfolded protein response-glutathione metabolism axis: A novel target of a cycloruthenated complexes bypassing tumor resistance mechanisms.
    Cancer Lett. 2024;585:216671.
    PubMed     Abstract available
    
    
    
37. ZHAO Z, Cai Z, Zhang S, Yin X, et al
    Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer.
    Cancer Lett. 2024 Mar 25:216796. doi: 10.1016/j.canlet.2024.216796.
    PubMed     Abstract available
    
    
    February 2024
38. CHANG M, Sun Q, Cui X, Wang Y, et al
    Lnc-PLCB1 is stabilized by METTL14 induced m6A modification and inhibits Helicobacter pylori mediated gastric cancer by destabilizing DDX21.
    Cancer Lett. 2024 Feb 20:216746. doi: 10.1016/j.canlet.2024.216746.
    PubMed     Abstract available
    
    
    
39. LIN C, Lin P, Yao H, Liu S, et al
    Modulation of YBX1-mediated PANoptosis inhibition by PPM1B and USP10 confers chemoresistance to oxaliplatin in gastric cancer.
    Cancer Lett. 2024 Feb 14:216712. doi: 10.1016/j.canlet.2024.216712.
    PubMed     Abstract available
    
    
    
40. LIANG B, Wu Q, Wang Y, Shi Y, et al
    Cdc42-driven endosomal cholesterol transport promotes collateral resistance in HER2-positive gastric cancer.
    Cancer Lett. 2024 Feb 7:216702. doi: 10.1016/j.canlet.2024.216702.
    PubMed     Abstract available
    
    
    January 2024
41. CHEN P, Zhong X, Song Y, Zhong W, et al
    Triptolide induces apoptosis and cytoprotective autophagy by ROS accumulation via directly targeting peroxiredoxin 2 in gastric cancer cells.
    Cancer Lett. 2024 Jan 19:216622. doi: 10.1016/j.canlet.2024.216622.
    PubMed     Abstract available
    
    
    
42. WU QN, Qi J, Liu ZK, Luo XJ, et al
    HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer.
    Cancer Lett. 2024 Jan 19:216643. doi: 10.1016/j.canlet.2024.216643.
    PubMed     Abstract available
    
    
    
43. WENG N, Zhou C, Zhou Y, Zhong Y, et al
    IKZF4/NONO-RAB11FIP3 axis promotes immune evasion in gastric cancer via facilitating PD-L1 endosome recycling.
    Cancer Lett. 2024 Jan 9:216618. doi: 10.1016/j.canlet.2024.216618.
    PubMed     Abstract available
    
    
    November 2023
44. WANG H, Zhou Z, Zhang J, Hao T, et al
    Pumilio1 regulates NPM3/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer.
    Cancer Lett. 2023;581:216498.
    PubMed     Abstract available
    
    
    
45. JIANG T, Xia Y, Li Y, Lu C, et al
    TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer.
    Cancer Lett. 2023;581:216510.
    PubMed     Abstract available
    
    
    October 2023
46. FENG W, Ma C, Rao H, Zhang W, et al
    Setd2 deficiency promotes gastric tumorigenesis through inhibiting the SIRT1/FOXO pathway.
    Cancer Lett. 2023 Oct 30:216470. doi: 10.1016/j.canlet.2023.216470.
    PubMed     Abstract available
    
    
    
47. HUA H, Su T, Han L, Zhang L, et al
    LINC01226 promotes gastric cancer progression through enhancing cytoplasm-to-nucleus translocation of STIP1 and stabilizing beta-catenin protein.
    Cancer Lett. 2023 Oct 6:216436. doi: 10.1016/j.canlet.2023.216436.
    PubMed     Abstract available
    
    
    September 2023
48. LI J, Feng H, Zhu J, Yang K, et al
    Gastric cancer derived exosomal THBS1 enhanced Vgamma9Vdelta2 T-cell function through activating RIG-I-like receptor signaling pathway in a N6-methyladenosine methylation dependent manner.
    Cancer Lett. 2023 Sep 30:216410. doi: 10.1016/j.canlet.2023.216410.
    PubMed     Abstract available
    
    
    August 2023
49. MAO D, Zhou Z, Chen H, Liu X, et al
    Pleckstrin-2 promotes tumour immune escape from NK cells by activating the MT1-MMP-MICA signalling axis in gastric cancer.
    Cancer Lett. 2023 Aug 15:216351. doi: 10.1016/j.canlet.2023.216351.
    PubMed     Abstract available
    
    
    
50. ANDREUCCI E, Biagioni A, Peri S, Versienti G, et al
    The CAIX inhibitor SLC-0111 exerts anti-cancer activity on gastric cancer cell lines and resensitizes resistant cells to 5-Fluorouracil, taxane-derived, and platinum-based drugs.
    Cancer Lett. 2023 Aug 5:216338. doi: 10.1016/j.canlet.2023.216338.
    PubMed     Abstract available
    
    
    July 2023
51. ZHAO P, Yuan F, Xu L, Jin Z, et al
    HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complex.
    Cancer Lett. 2023 Jul 7:216305. doi: 10.1016/j.canlet.2023.216305.
    PubMed     Abstract available
    
    
    May 2023
52. CHEN Z, Xu P, Wang X, Li Y, et al
    MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer.
    Cancer Lett. 2023;565:216235.
    PubMed     Abstract available
    
    
    April 2023
53. LI M, Mei YX, Wen JH, Jiao YR, et al
    Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
    Cancer Lett. 2023;559:216104.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.